Friday, September 25, 2015
Tuesday, September 22, 2015
Doctor's Choice: DMF-Melatonin May Be One Of The Most Effective Ant...: DMF-Melatonin May Be One of the Most Effective Anti-Cancer Treatments in Existence Numerous studies have established melatonin as one of...
DMF-Melatonin May Be One of the Most Effective Anti-Cancer Treatments in Existence
Numerous studies have established melatonin as one of the most effective anti-cancer treatments in existence. It inhibits cancer cell growth and proliferation; it destroys cancer cells, stops angiogenesis (new tumor blood vessel growth), and prevents harmful forms of estrogen from stimulating cancer cell growth.
In one clinical trial, patients with glioblastoma, a type of brain cancer, were given either radiation and melatonin, or radiation alone. Twenty-three percent of the patients who took the melatonin were alive after a year, while none who had received only radiation were still alive. Similarly, in another study by oncologists in Italy, patients with non-small cell lung cancers who had failed chemotherapy were given melatonin. They were compared with other patients with non-small cell lung cancers who weren't given melatonin. A year later, 26 percent of the patients who had taken melatonin were still alive; whereas, none in the non-melatonin group remained alive.
Studies have also revealed melatonin to be more effective for treating pancreatic and lung cancers than a drug commonly used to treat these types of cancers. What's more, this drug may cost more than $4,000 per month, while twenty milligrams of DMF melatonin cost approximately $50 per month.
Note: Do You Think All Melatonin’s Are The Same? Many clinical studies support the use of melatonin for conditions ranging from concussions to cancer therapy, the version used is DMF (drug manufactured file), USP (United State Pharmacopeia) melatonin the same used by Doctor’s Choice® Unlike commercial brands that use synthetic or either animal-derived hormones; which is less effective. Doctor’s Choice® starting position origin is L-tryptophan, a known serotonin releaser (See below: Life Choice Melatonin)
This pathway produces a number of important chemicals, including serotonin, as intermediates. It takes a total of four reactions to bring about the change from tryptophan to melatonin, and each of these reactions requires its own specific enzyme. One of these enzymes acts as the rate-limiting enzyme in the reaction pathway, and its activity determines how much melatonin is produced. The rate-limiting enzyme in this reaction is the serotonin-N-acetyl transferase.
Melatonin functions to destroy cancer in multiple ways. First, because it is toxic to cancer cells, it induces apoptosis, or cancer cell auto-destruction, as well as directly kills cancer cells. It also slows tumor growth through a variety of mechanisms, such as by inhibiting epidermal growth factor receptors on cancer cells.
Epidermal growth factors play an important role in cancer cell growth and proliferation, so blocking their receptors on cancer cells prevents them from carrying out these roles.
Melatonin also stimulates the immune system and increases the cancer-killing activity of macrophages, monocytes, natural killer cells, T-helper cells and eosinophils, all of which are involved in cancer cell destruction.
Additionally, melatonin inhibits angiogenesis (new tumor blood vessel creation) from existing blood vessels. Tumors get their nutrition through blood vessels, and as they grow, they require an increasingly greater supply of blood vessels to feed themselves. Preventing new blood vessel growth limits their food intake and causes them to shrink or stop growing.
Melatonin has properties which enable it to block the effects of estrogen upon cancer cells; this is important because certain forms of estrogen stimulate the growth of hormonally-influenced cancers, such as breast, endometrial, ovarian and uterine cancers.
Finally, as an antioxidant, melatonin reduces inflammation, a condition that enables cancer's survival, and it scavenges free radicals so that they don't damage normal cells and make them vulnerable to further genetic mutations.
Despite these favorable statistics, melatonin is seldom recommended to patients in conventional medicine because the laws which govern the practice of medicine are drastically influenced by pharmaceutical interests, which prevent doctors from recommending it to their patients in lieu of expensive, damaging chemotherapy drugs. It is, however, an effective natural treatment that not only helps to prevent cancer, but which also plays an integral role in healing the body from it.
Doctor’s Choice® uses the purest source of melatonin in the world. We only use 100% DMF (drug master file) patented pharmaceutical grade raw material; paying 700% more for our raw material than can be purchased without a patent. Why? The reasons are two-fold: first, the material is clinically researched, and secondly, the quality is consistently high with each order. Small batch manufacturing and the selection of raw materials create the difference that your body will notice.
Recommended dosage of melatonin liquid for adults is 5ml-15ml per day.
Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture
Prostate Cancer Linked to Melatonin in New Study: Can the Sleep Hormone Help Lower Risk of the Disease?
What is the role of melatonin in the management of sleep disorders in children?
Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol.
Role of melatonin on diabetes-related metabolic disorders
Friday, September 18, 2015
Doctor's Choice: Natural Alternatives for Female Sex Drive: The latest news from Doctor's Choice! View this email in your browser Natural Alternatives for Female S...
Doctor's Choice: Natural Health: Immunity Tips For Back To School: The latest news from Doctor's Choice! View this email in your browser Immunity Tips for Back to School ...
Thursday, September 10, 2015